🇺🇸 FDA
Patent

US 8906863

Proteolysis-resistant capsid of chimeric hepatitis E virus as an oral delivery vector

granted A61KA61K2039/5258A61K2039/53

Quick answer

US patent 8906863 (Proteolysis-resistant capsid of chimeric hepatitis E virus as an oral delivery vector) held by The Regents of the University of California expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K2039/5258, A61K2039/53, A61K2039/541, A61K2039/542